Viola Barucca

672 total citations
19 papers, 496 citations indexed

About

Viola Barucca is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Viola Barucca has authored 19 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Viola Barucca's work include Pancreatic and Hepatic Oncology Research (7 papers), Cancer Treatment and Pharmacology (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). Viola Barucca is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Cancer Treatment and Pharmacology (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). Viola Barucca collaborates with scholars based in Italy and Malaysia. Viola Barucca's co-authors include Paolo Marchetti, Adriana Romiti, Chiara D’Antonio, Gianfranco Delle Fave, Giulia Zerboni, Roberto Valente, Lívia Archibugi, Serena Stigliano, Gabriele Capurso and Matteo Piciucchi and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Viola Barucca

18 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Viola Barucca Italy 13 343 116 115 111 90 19 496
Oktay Bozkurt Türkiye 13 248 0.7× 105 0.9× 59 0.5× 113 1.0× 88 1.0× 44 427
Kristin Kaley United States 12 323 0.9× 85 0.7× 77 0.7× 101 0.9× 63 0.7× 36 447
Hossein Sadrzadeh United States 13 156 0.5× 94 0.8× 84 0.7× 54 0.5× 191 2.1× 35 673
Maria Maddalena Laterza Italy 10 192 0.6× 79 0.7× 81 0.7× 143 1.3× 59 0.7× 35 342
Zeki Üstüner Türkiye 11 219 0.6× 51 0.4× 121 1.1× 124 1.1× 115 1.3× 24 562
Alexandros Papalambros Greece 12 161 0.5× 70 0.6× 140 1.2× 99 0.9× 90 1.0× 25 402
Mustafa Altınbaş Türkiye 12 202 0.6× 69 0.6× 103 0.9× 120 1.1× 145 1.6× 47 670
Koichi Motojima Japan 13 386 1.1× 124 1.1× 233 2.0× 76 0.7× 104 1.2× 27 558
Alessandro Parisi Italy 11 208 0.6× 36 0.3× 74 0.6× 119 1.1× 62 0.7× 56 404
Süleyman Alıcı Türkiye 12 258 0.8× 66 0.6× 142 1.2× 136 1.2× 77 0.9× 40 540

Countries citing papers authored by Viola Barucca

Since Specialization
Citations

This map shows the geographic impact of Viola Barucca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viola Barucca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viola Barucca more than expected).

Fields of papers citing papers by Viola Barucca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viola Barucca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viola Barucca. The network helps show where Viola Barucca may publish in the future.

Co-authorship network of co-authors of Viola Barucca

This figure shows the co-authorship network connecting the top 25 collaborators of Viola Barucca. A scholar is included among the top collaborators of Viola Barucca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viola Barucca. Viola Barucca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bassanelli, Maria, Biagio Ricciuti, Diana Giannarelli, et al.. (2021). Systemic effect of radiotherapy before or after nivolumab in lung cancer: an observational, retrospective, multicenter study. Tumori Journal. 108(3). 250–257. 9 indexed citations
2.
Barrea, Luigi, Marco Gallo, Rosaria Maddalena Ruggeri, et al.. (2020). Nutritional status and follicular-derived thyroid cancer: An update. Critical Reviews in Food Science and Nutrition. 61(1). 25–59. 77 indexed citations
3.
Guerra, Francesco, Viola Barucca, & Diego Coletta. (2020). Metastases or primary recurrence to the lung is related to improved survival of pancreatic cancer as compared to other sites of dissemination. Results of a systematic review with meta-analysis. European Journal of Surgical Oncology. 46(10). 1789–1794. 17 indexed citations
4.
Bassanelli, Maria, Diana Giannarelli, Maria Rita Migliorino, et al.. (2019). Immunotherapy discontinuation and outcome: A multicenter real-life experience.. Journal of Clinical Oncology. 37(15_suppl). e14075–e14075.
5.
Antonuzzo, Lorenzo, Marzia Del Re, Viola Barucca, et al.. (2017). Critical focus on mechanisms of resistance and toxicity of m-TOR inhibitors in pancreatic neuroendocrine tumors. Cancer Treatment Reviews. 57. 28–35. 16 indexed citations
6.
Archibugi, Lívia, Matteo Piciucchi, Serena Stigliano, et al.. (2017). Exclusive and Combined Use of Statins and Aspirin and the Risk of Pancreatic Cancer: a Case-Control Study. Scientific Reports. 7(1). 13024–13024. 38 indexed citations
7.
Piciucchi, Matteo, Serena Stigliano, Lívia Archibugi, et al.. (2017). The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients. International Journal of Molecular Sciences. 18(4). 730–730. 58 indexed citations
8.
Romiti, Adriana, Michela Roberto, Chiara D’Antonio, et al.. (2016). The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer. Anti-Cancer Drugs. 27(10). 1044–1049. 13 indexed citations
9.
Romiti, Adriana, Concetta Elisa Onesti, Michela Roberto, et al.. (2015). Continuous, low-dose capecitabine for patients with recurrent colorectal cancer. Medical Oncology. 32(3). 54–54. 24 indexed citations
10.
Piciucchi, Matteo, Gabriele Capurso, Roberto Valente, et al.. (2015). Early onset pancreatic cancer: Risk factors, presentation and outcome. Pancreatology. 15(2). 151–155. 62 indexed citations
11.
Roberto, Michela, Adriana Romiti, Concetta Elisa Onesti, et al.. (2015). A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer. Anti-Cancer Drugs. 27(2). 106–111. 13 indexed citations
12.
Romiti, Adriana, Salvatore Raffa, Michela Roberto, et al.. (2014). Circulating Tumor Cells Count Predicts Survival in Colorectal Cancer Patients. Journal of Gastrointestinal and Liver Diseases. 23(3). 279–284. 40 indexed citations
13.
Spada, Francesca, Caterina Fumagalli, Lorenzo Antonuzzo, et al.. (2014). Capecitabine plus temozolomide (CAP-TEM) in patients with advanced neuroendocrine neoplasms (NEN): An Italian multicenter retrospective analysis.. Journal of Clinical Oncology. 32(3_suppl). 281–281. 10 indexed citations
14.
Romiti, Adriana, et al.. (2013). Metronomic chemotherapy for cancer treatment: a decade of clinical studies. Cancer Chemotherapy and Pharmacology. 72(1). 13–33. 69 indexed citations
15.
Romiti, Adriana, Massimo Milione, Luigi Ruco, et al.. (2012). Somatostatin receptor subtype 2 A (SSTR2A) and HER2 expression in gastric adenocarcinoma.. PubMed. 32(1). 115–9. 4 indexed citations
16.
Torre, Marco La, Laura Lorenzon, Emanuela Pilozzi, et al.. (2012). Number of harvested lymph nodes is the main prognostic factor in Stage IIa colorectal cancer patients. Journal of Surgical Oncology. 106(4). 469–474. 25 indexed citations
17.
Romiti, Adriana, et al.. (2012). Chemotherapy for the Biliary Tract Cancers: Moving Toward Improved Survival Time. Journal of Gastrointestinal Cancer. 43(3). 396–404. 15 indexed citations
18.
Rossi, Luigi, Angelo Zullo, Federica Zoratto, et al.. (2012). P-0270 Impact of Kras and Braf Gene Mutation Status on Outcomes of Chemotherapy in Combination with Bevacizumab in Metastatic Colorectal Cancer. Annals of Oncology. 23. iv108–iv108. 1 indexed citations
19.
Rossi, Luigi, Enzo Veltri, Angelo Zullo, et al.. (2012). Bevacizumab Plus Chemotherapy in Metastatic Colorectal Cancer Patients Treated in Clinical Practice. Future Oncology. 8(9). 1193–1197. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oktay Bozkurt Breakdown of academic impact, for papers by Kristin Kaley Breakdown of academic impact, for papers by Hossein Sadrzadeh Breakdown of academic impact, for papers by Maria Maddalena Laterza Breakdown of academic impact, for papers by Zeki Üstüner Breakdown of academic impact, for papers by Alexandros Papalambros Breakdown of academic impact, for papers by Mustafa Altınbaş Breakdown of academic impact, for papers by Koichi Motojima Breakdown of academic impact, for papers by Alessandro Parisi Breakdown of academic impact, for papers by Süleyman Alıcı
Rankless by CCL
2026